Passive transfer of anti-IgLON5 antibodies induces symptoms in mice and reduces IgLON5 expression, but not sleep symptoms‼️
Could tau deposition be the missing link behind the sleep phenotype?
Fascinating to see how quickly we are unraveling #IgLON5 disease🔝
On @GreenJournal 👇🏽
New study published in @GreenJournal: Genetics for high pulse pressure associated with higher risk of #dementia-related death: https://t.co/zuQdWzoVe0
#AANscience#Neurology
Acute Kidney Injury and Risk of Adverse Neurocognitive Outcomes: A Systematic Review and Meta-Analysis Acute Kidney Injury and Risk of Adverse Neurocognitive Outcomes https://t.co/B5H6jp3Ng2
#Dementia#Stroke
Nerve biopsies were more sensitive than fat aspirate or skin biopsy in detecting amyloid in a retrospective cohort of patients with symptomatic hereditary ATTR amyloidosis w/ peripheral neuropathy. Skin biopsy was slightly more sensitive than fat aspirate: https://t.co/pU7qSOEntb
Guido et al. explored resting-state functional connectivity of the central autonomic network in multiple sclerosis, its relationship with fatigue severity, and its modifications after aerobic training (AT) vs non-AT: https://t.co/bNHqgTAysT
Neurology Podcast: Drs. Andy Southerland & Dan Ackerman discuss the latest guidelines for managing acute ischemic #stroke, emphasizing thrombolytic therapy, imaging techniques, and decision-making regarding treatment in extended time windows. Listen now: https://t.co/ITo3D14q2W
In the latest Neurology Resident & Fellow Section blog, learn about Mission Thrombectomy, a SVIN-led global effort to expand access to mechanical thrombectomy and reduce stroke care disparities: https://t.co/l2HJZekYcL
#NeurologyRF@dyavagal@MThrombectomy@svinsociety
This Norwegian nationwide registry-based cohort study revealed a substantial increase in cluster headache prevalence from 2009 to 2022, accompanied by a notable shift from predominance in men to predominance in women: https://t.co/GCzEJWdQpE
This study provides Class I evidence that in patients with acute trigeminal neuralgia exacerbations, IV fosphenytoin is superior to placebo in reducing pain intensity at 120 minutes: https://t.co/mgjpobLnEi
In this episode of the Neurology Podcast: The June 2026 Recall highlights four previously posted episodes on #ParkinsonianDisorders. Listen now: https://t.co/pEnaEl53CE
@DrJeffRatliff
🚨 Neurology residents worldwide are invited to apply for a 3‑year term on the Neurology Resident & Fellow Section Editorial Board.
📆 Application deadline: July 13, 2026
🔗 Details: https://t.co/QFkCrJSVGl
#NeurologyRF#NeuroTwitter
Epstein-Barr virus-positive infectious mononucleosis was associated with an approximately 3-fold higher risk of #MultipleSclerosis in this population-based retrospective cohort study: https://t.co/vBEZLz7sM8
It's time for journal history trivia! Put your answer in the comments and visit https://t.co/LZ486kiM8J to learn more about the last 75 years of Neurology. #Neurology75
Class II evidence that CGRP inhibitor (CGRPi) users with migraine have a lower risk of incident glaucoma when compared with non-CGRPi users with #migraine: https://t.co/EC2w3bXCC4